Obesity Bmi 30kg M2 clinical trials

Explore recruiting obesity bmi 30kg m2 clinical trials.

Also recruiting in Europe

Obesity Bmi 30kg M2 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The impact of pramlintide on top of semaglutide in obese people with prediabetes

Denmark

Phase II and Phase III (Integrated) EU CTIS Study details

Impact of Oral Semaglutide on Platelet Reactivity in Patients with Diabetes Mellitus or Overweight with High Risk or established Cardiovascular Disease: the SEMA-PLAT Study

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Obesity Bmi 30kg M2 trials by city

Obesity Bmi 30kg M2 in Toronto Obesity Bmi 30kg M2 in Vancouver Obesity Bmi 30kg M2 in Montreal Obesity Bmi 30kg M2 in Calgary Obesity Bmi 30kg M2 in Edmonton Obesity Bmi 30kg M2 in Ottawa Obesity Bmi 30kg M2 in Winnipeg Obesity Bmi 30kg M2 in Quebec City Obesity Bmi 30kg M2 in Hamilton Obesity Bmi 30kg M2 in Kitchener Obesity Bmi 30kg M2 in London Obesity Bmi 30kg M2 in Halifax Obesity Bmi 30kg M2 in New York Obesity Bmi 30kg M2 in Los Angeles Obesity Bmi 30kg M2 in Chicago Obesity Bmi 30kg M2 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease